CN Stock MarketDetailed Quotes
600351 Yabao Pharmaceutical Group
- 6.56
- +0.12+1.86%
Market Closed Dec 2 15:00 CST
4.72BMarket Cap21.37P/E (TTM)
6.58High6.46Low300.68KlotVolume6.46Open6.44Pre Close196.15MTurnover4.18%Turnover Ratio23.68P/E (Static)720.00MShares7.4952wk High1.60P/B4.72BFloat Cap4.7952wk Low7.08Limit Up720.00MShs Float18.68Historical High5.80Limit Down1.86%Amplitude-0.64Historical Low0.15Dividend TTM6.52Avg Price136.93KlotAsk2.29%Div YieldTTM100Lot Size159.12KlotBid
Yabao Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -10.96%1.84B | -7.92%1.29B | 9.85%738.7M | 15.31%2.81B | 21.63%2.07B | 22.12%1.4B | 14.07%672.43M | -6.72%2.44B | -13.15%1.7B | -17.03%1.14B |
| Refunds of taxes and levies | 0.28%1.91M | 64.54%1.76M | 121.98%1.3M | -77.24%2.86M | -83.89%1.91M | -90.82%1.07M | 60.01%586.09K | 3,175.22%12.56M | 2,148.24%11.84M | 2,931.11%11.62M |
| Cash received relating to other operating activities | -26.03%53.72M | 34.84%59.41M | 39.87%36.86M | 2.24%85.51M | -58.17%72.62M | -59.07%44.06M | 110.34%26.35M | 27.38%83.63M | 251.62%173.62M | 223.36%107.65M |
| Cash inflows from operating activities | -11.46%1.9B | -6.56%1.35B | 11.08%776.86M | 14.42%2.9B | 13.63%2.15B | 14.17%1.44B | 16.10%699.37M | -5.43%2.53B | -6.08%1.89B | -10.57%1.26B |
| Goods services cash paid | -12.45%496.28M | -12.33%318.6M | -15.41%170.86M | 26.55%771.16M | 41.87%566.85M | 43.71%363.4M | 62.20%201.99M | 5.88%609.36M | 2.70%399.54M | 6.43%252.87M |
| Staff behalf paid | -4.39%359.23M | -4.64%250.01M | -3.27%128.29M | -1.41%485.95M | 1.29%375.73M | 1.65%262.17M | 1.39%132.62M | 1.45%492.91M | 4.75%370.96M | 6.61%257.92M |
| All taxes paid | -3.71%209.67M | -7.01%145.6M | -27.85%63.87M | 24.44%288.88M | 21.73%217.76M | 40.59%156.57M | 39.15%88.52M | -1.23%232.15M | -3.51%178.89M | -13.60%111.37M |
| Cash paid relating to other operating activities | -30.54%451.94M | -28.13%291.75M | -26.03%134.48M | 15.78%856.41M | -7.19%650.62M | -9.67%405.94M | -22.11%181.81M | -21.82%739.69M | -13.15%701.03M | -6.62%449.39M |
| Cash outflows from operating activities | -16.22%1.52B | -15.33%1.01B | -17.76%497.5M | 15.83%2.4B | 9.73%1.81B | 10.87%1.19B | 9.52%604.94M | -7.51%2.07B | -4.92%1.65B | -1.66%1.07B |
| Net cash flows from operating activities | 14.31%382.42M | 34.31%342.14M | 195.85%279.36M | 8.06%497.55M | 40.75%334.54M | 32.53%254.74M | 88.76%94.43M | 5.25%460.46M | -13.44%237.69M | -40.58%192.21M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -77.08%4.87M | -68.62%4.87M | -80.57%743.93K | -51.06%61.02M | -69.20%21.25M | -70.27%15.52M | -79.16%3.83M | -0.73%124.67M | -30.24%69M | -36.96%52.2M |
| Cash received from returns on investments | 1,273.61%1.15M | 1,281.29%1.11M | 2,288.79%1.19M | -92.11%404.21K | -98.99%84.01K | -98.88%80.25K | 2,544.51%49.99K | -7.32%5.12M | 98.77%8.32M | 71.95%7.19M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 70.04%884.78K | -35.44%144.86K | 36.29%132.2K | 1,063.65%14.59M | 2.66%520.35K | -28.51%224.39K | -50.21%97K | 10.04%1.25M | -32.78%506.86K | 22.73%313.86K |
| Cash inflows from investing activities | -68.39%6.91M | -61.30%6.12M | -47.94%2.07M | -42.00%76.01M | -71.92%21.85M | -73.50%15.82M | -78.59%3.98M | -0.91%131.04M | -25.06%77.83M | -31.56%59.71M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -64.62%28.32M | -68.05%15.76M | -52.41%10.15M | 60.46%99.86M | 85.90%80.06M | 73.41%49.31M | 28.85%21.32M | -34.53%62.23M | -37.90%43.07M | -46.92%28.44M |
| Cash paid to acquire investments | -74.79%17.38M | -29.81%15.09M | -92.06%926.29K | -37.46%103.53M | -32.23%68.95M | -78.15%21.5M | -76.73%11.67M | 1.83%165.54M | -26.24%101.73M | -13.93%98.4M |
| Net cash paid to acquire subsidiaries and other business units | --5K | --5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -69.33%45.7M | -56.43%30.86M | -66.43%11.07M | -10.71%203.38M | 2.91%149.01M | -44.17%70.82M | -50.53%32.99M | -11.58%227.77M | -30.14%144.8M | -24.46%126.84M |
| Net cash flows from investing activities | 69.49%-38.8M | 55.03%-24.73M | 68.97%-9M | -31.68%-127.37M | -89.88%-127.15M | 18.08%-54.99M | 39.69%-29.01M | 22.84%-96.73M | 35.25%-66.96M | 16.77%-67.13M |
| Financing cash flow | ||||||||||
| Cash from borrowing | -74.18%90M | -30.72%90M | -35.67%90M | -43.73%348.6M | -37.72%348.6M | -68.30%129.9M | -50.03%139.9M | 18.80%619.53M | 19.13%559.73M | 17.09%409.8M |
| Cash received relating to other financing activities | --43.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | -61.63%133.74M | -30.72%90M | -35.67%90M | -43.73%348.6M | -37.72%348.6M | -68.30%129.9M | -50.03%139.9M | 18.80%619.53M | 19.13%559.73M | 17.09%409.8M |
| Borrowing repayment | -62.58%202M | -59.09%90M | -30.77%90M | -17.29%589.4M | -3.92%539.8M | -53.17%220M | -48.00%130M | 10.78%712.6M | 16.41%561.8M | 8.63%469.8M |
| Dividend interest payment | 129.53%112.78M | 138.56%111.09M | -53.08%1.8M | -37.18%51.26M | -34.67%49.14M | -34.24%46.57M | -12.97%3.83M | 35.11%81.61M | 36.34%75.21M | 42.76%70.81M |
| Cash payments relating to other financing activities | 70.17%177.04M | 139.46%175.59M | 7,593.43%174.28M | 3,812.51%154.69M | 2,782.07%104.04M | 2,032.97%73.32M | -24.34%2.27M | -10.79%3.95M | --3.61M | --3.44M |
| Cash outflows from financing activities | -29.03%491.82M | 10.82%376.67M | 95.51%266.08M | -0.35%795.35M | 8.17%692.98M | -37.53%339.89M | -47.13%136.1M | 12.72%798.16M | 19.12%640.62M | 12.86%544.04M |
| Net cash flows from financing activities | -3.98%-358.08M | -36.52%-286.67M | -4,724.71%-176.08M | -150.09%-446.75M | -325.71%-344.38M | -56.42%-209.99M | -83.16%3.81M | 4.28%-178.64M | -19.08%-80.89M | -1.65%-134.24M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 505.91%47.15K | 245.68%49.69K | 145.34%31.48K | -94.23%12.83K | -102.49%-11.61K | -89.36%14.37K | -1,224.60%-69.43K | 534.44%222.39K | 1,633.45%465.86K | 500.60%135.15K |
| Net increase in cash and cash equivalents | 89.48%-14.41M | 401.00%30.79M | 36.38%94.31M | -141.31%-76.56M | -251.73%-137.01M | -13.19%-10.23M | 181.98%69.15M | 47.71%185.32M | -12.53%90.3M | -108.16%-9.04M |
| Add:Begin period cash and cash equivalents | -11.92%565.46M | -11.92%565.46M | -11.92%565.46M | 40.58%642.02M | 40.58%642.02M | 40.58%642.02M | 40.58%642.02M | 37.88%456.7M | 37.88%456.7M | 37.88%456.7M |
| End period cash equivalent | 9.12%551.05M | -5.63%596.25M | -7.23%659.78M | -11.92%565.46M | -7.68%505.02M | 41.13%631.79M | 47.78%711.18M | 40.58%642.02M | 25.90%547M | 1.29%447.67M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data